Abstract
Daily vitamin D3 supplementation at higher than standardized doses for the first two years of life decreases the risk of psychiatric symptoms at ages 6 to 8 years, a new study has found. The study, a secondary analysis of a randomized clinical trial with 346 children, found that those randomized to higher vitamin D3 supplementation were less likely to have clinically significant internalizing problems later.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child & Adolescent Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
